JP Morgan Chase’s Veracyte VCYT Stock Holding History

JP Morgan Chase’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,000	Closed	-$135K	–	4971
2016 Q1	$135K	Buy	+25,000	New	+$148K	﹤0.01%	3694

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase's VCYT Position: Q2 2026 in Review

JP Morgan Chase increased its Veracyte (VCYT) stake by 3.9% in Q2 2026, buying an estimated $806K and bringing the position to 515,452 shares worth $31.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

JP Morgan Chase first reported a position in VCYT in Q3 2016 and has held it in 39 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

JP Morgan Chase held 515,452 shares of Veracyte worth $31.2M as of Q2 2026.
JP Morgan Chase bought 19,233 Veracyte shares in Q2 2026, an estimated $806K.
Veracyte made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1842 holding.
JP Morgan Chase first reported a position in Veracyte in Q3 2016 and has held it in 39 quarters since.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.